Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
Brief Summary: This is a multi-center phase III study to compare the clinical benefit of androgen deprivation therapy with or without docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate cancer.


Options:
A: Arm Label: Enzalutamide; Type: EXPERIMENTAL; Interventions: Drug: Enzalutamide, Drug: LHRHA or Surgical Castration | Arm Label: Conventional NSAA; Type: ACTIVE_COMPARATOR; Interventions: Drug: NSAA, Drug: LHRHA or Surgical Castration | Intervention Type: DRUG; Name: Enzalutamide; Assigned to Arm(s): Enzalutamide | Intervention Type: DRUG; Name: NSAA; Assigned to Arm(s): Conventional NSAA | Intervention Type: DRUG; Name: LHRHA or Surgical Castration; Assigned to Arm(s): Conventional NSAA, Enzalutamide
B: Arm Label: Abiraterone acetate + Prednisone + ADT; Type: EXPERIMENTAL; Interventions: Drug: Abiraterone acetate, Drug: Prednisone, Other: Androgen deprivation therapy (ADT) | Arm Label: Placebo + Androgen Deprivation Therapy (ADT); Type: PLACEBO_COMPARATOR; Interventions: Other: Androgen deprivation therapy (ADT), Drug: Abiraterone acetate Placebo, Drug: Prednisone Placebo | Intervention Type: DRUG; Name: Abiraterone acetate; Assigned to Arm(s): Abiraterone acetate + Prednisone + ADT | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Abiraterone acetate + Prednisone + ADT | Intervention Type: OTHER; Name: Androgen deprivation therapy (ADT); Assigned to Arm(s): Abiraterone acetate + Prednisone + ADT, Placebo + Androgen Deprivation Therapy (ADT) | Intervention Type: DRUG; Name: Abiraterone acetate Placebo; Assigned to Arm(s): Placebo + Androgen Deprivation Therapy (ADT) | Intervention Type: DRUG; Name: Prednisone Placebo; Assigned to Arm(s): Placebo + Androgen Deprivation Therapy (ADT)
C: Arm Label: Placebo + prednisone; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Prednisone | Arm Label: Abiraterone + prednisone; Type: EXPERIMENTAL; Interventions: Drug: Abiraterone acetate, Drug: Prednisone | Intervention Type: DRUG; Name: Abiraterone acetate; Assigned to Arm(s): Abiraterone + prednisone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + prednisone | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Abiraterone + prednisone, Placebo + prednisone
D: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Other: Androgen Deprivation Therapy, Drug: Docetaxel | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Drug: abiraterone acetate, Other: Androgen Deprivation Therapy, Drug: Docetaxel | Arm Label: Arm C; Type: EXPERIMENTAL; Interventions: Radiation: radiotherapy, Other: Androgen Deprivation Therapy, Drug: Docetaxel | Arm Label: Arm D; Type: EXPERIMENTAL; Interventions: Drug: abiraterone acetate, Radiation: radiotherapy, Other: Androgen Deprivation Therapy, Drug: Docetaxel | Intervention Type: DRUG; Name: abiraterone acetate; Assigned to Arm(s): Arm B, Arm D | Intervention Type: RADIATION; Name: radiotherapy; Assigned to Arm(s): Arm C, Arm D | Intervention Type: OTHER; Name: Androgen Deprivation Therapy; Assigned to Arm(s): Arm A, Arm B, Arm C, Arm D | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Arm A, Arm B, Arm C, Arm D

Answer: D